Literature DB >> 19056352

4-HNE inhibits tube formation and up-regulates chondromodulin-I in human endothelial cells.

Dimitrios Stagos1, Hongfei Zhou, David Ross, Vasilis Vasiliou.   

Abstract

The aim of the present study was to investigate the effects of 4-hydroxy-2-nonenal (4-HNE) on tube formation by human bone marrow endothelial cells (HBMEC). We found that 4-HNE at physiologically achievable concentrations (5 and 10 microM) inhibited the formation of tubes. Western blot analysis revealed that inhibition of tube formation by 4-HNE was associated with increased expression of chondromodulin-I (CHM-I), a protein with well-known anti-angiogenic properties. Cell viability assays showed that 4-HNE at concentrations of 10 microM or less did not cause HBMEC cell death. Luciferase reporter assays did not show any inducing effect of 4-HNE on the promoter activity of human CHM-I gene indicating that post-transcriptional or post-translational modifications may account for the up-regulation of CHM-I. Collectively, the results of the present study show for the first time that 4-HNE inhibits tube formation by HBMECs indicating a potential anti-angiogenic activity of 4-HNE. This inhibition occurs at least in part via 4-HNE-induced CHM-I protein expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056352      PMCID: PMC2757412          DOI: 10.1016/j.bbrc.2008.11.095

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Review: A case for corneal crystallins.

Authors:  J Piatigorsky
Journal:  J Ocul Pharmacol Ther       Date:  2000-04       Impact factor: 2.671

2.  Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye.

Authors:  H Funaki; S Sawaguchi; K Yaoeda; Y Koyama; E Yaoita; S Funaki; M Shirakashi; Y Oshima; C Shukunami; Y Hiraki; H Abe; T Yamamoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

3.  Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea.

Authors:  Aglaia Pappa; Tia Estey; Rizwan Manzer; Donald Brown; Vasilis Vasiliou
Journal:  Biochem J       Date:  2003-12-15       Impact factor: 3.857

Review 4.  AP-1 in mouse development and tumorigenesis.

Authors:  W Jochum; E Passegué; E F Wagner
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

5.  Structurally normal corneas in aldehyde dehydrogenase 3a1-deficient mice.

Authors:  David W Nees; Eric F Wawrousek; W Gerald Robison; Joram Piatigorsky
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

6.  Genomic organization of the human chondromodulin-1 gene containing a promoter region that confers the expression of reporter gene in chondrogenic ATDC5 cells.

Authors:  I Yanagihara; M Yamagata; N Sakai; C Shukunami; H Kurahashi; M Yamazaki; T Michigami; Y Hiraki; K Ozono
Journal:  J Bone Miner Res       Date:  2000-03       Impact factor: 6.741

7.  Generation of multiple angiogenesis inhibitors by human pancreatic cancer.

Authors:  O Kisker; S Onizuka; J Banyard; T Komiyama; C M Becker; E G Achilles; C M Barnes; M S O'Reilly; J Folkman; S R Pirie-Shepherd
Journal:  Cancer Res       Date:  2001-10-01       Impact factor: 12.701

Review 8.  Molecular mechanisms underlying the onset of degenerative aortic valve disease.

Authors:  Daihiko Hakuno; Naritaka Kimura; Masatoyo Yoshioka; Keiichi Fukuda
Journal:  J Mol Med (Berl)       Date:  2008-09-03       Impact factor: 4.599

9.  Cartilage-specific matrix protein, chondromodulin-I (ChM-I), is a strong angio-inhibitor in endochondral ossification of human neonatal vertebral tissues in vivo: relationship with angiogenic factors in the cartilage.

Authors:  Kimihide Kusafuka; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Acta Histochem       Date:  2002       Impact factor: 2.479

10.  Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model.

Authors:  Surya P Ayalasomayajula; Uday B Kompella
Journal:  Eur J Pharmacol       Date:  2003-01-05       Impact factor: 4.432

View more
  3 in total

1.  4-Hydroxynonenal Contributes to Angiogenesis through a Redox-Dependent Sphingolipid Pathway: Prevention by Hydralazine Derivatives.

Authors:  Caroline Camaré; Corinne Vanucci-Bacqué; Nathalie Augé; Mélanie Pucelle; Corinne Bernis; Audrey Swiader; Michel Baltas; Florence Bedos-Belval; Robert Salvayre; Anne Nègre-Salvayre
Journal:  Oxid Med Cell Longev       Date:  2017-04-05       Impact factor: 6.543

Review 2.  The Potential Role of Mitochondrial Acetaldehyde Dehydrogenase 2 in Urological Cancers From the Perspective of Ferroptosis and Cellular Senescence.

Authors:  Weizhen Zhu; Dechao Feng; Xu Shi; Qiang Wei; Lu Yang
Journal:  Front Cell Dev Biol       Date:  2022-04-20

3.  The "two-faced" effects of reactive oxygen species and the lipid peroxidation product 4-hydroxynonenal in the hallmarks of cancer.

Authors:  Stefania Pizzimenti; Cristina Toaldo; Piergiorgio Pettazzoni; Mario U Dianzani; Giuseppina Barrera
Journal:  Cancers (Basel)       Date:  2010-03-30       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.